We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+43.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.75B
AUM Growth
+$811M
Cap. Flow
+$363M
Cap. Flow %
13.21%
Top 10 Hldgs %
44.65%
Holding
241
New
88
Increased
39
Reduced
33
Closed
64

Top Buys

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$36.2M
2
HYFM icon
Hydrofarm Holdings
HYFM
+$19.6M
3
LUNG icon
Pulmonx
LUNG
+$19.2M
4
SEER icon
Seer Inc
SEER
+$18.7M
5
ABCL icon
AbCellera Biologics
ABCL
+$16.7M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$27M
2
INSP icon
Inspire Medical Systems
INSP
+$11.3M
3
PPD
PPD, Inc. Common Stock
PPD
+$11.1M
4
STAA icon
STAAR Surgical
STAA
+$10.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$9.3M

Sector Composition

Rank Sector Weight
1 Healthcare 34.42%
2 Industrials 1.65%
3 Consumer Staples 0.32%
4 Financials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
51
CALL
Sarepta Therapeutics
SRPT
$1.94B
$14.3M 0.52%
84,000
+30,000
+56% +$4.45M
PSNL icon
52
Personalis
PSNL
$1.52B
$14.3M 0.52%
389,771
-141,500
-27% -$4.28M
ORGO icon
53
Organogenesis Holdings
ORGO
$233M
$13.6M 0.49%
+1,807,554
New +$8.58M
AFIB
54
DELISTED
Acutus Medical Inc
AFIB
$13.5M 0.49%
473,146
-61,852
-12% -$1.67M
PPH icon
55
PUT
VanEck Pharmaceutical ETF
PPH
$990M
$13.3M 0.48%
200,000
+100,000
+100% +$6.41M
ZBH icon
56
Zimmer Biomet
ZBH
$18.7B
$13.2M 0.48%
87,913
+3,605
+4% +$509K
IRTC icon
57
PUT
iRhythm Holdings
IRTC
$4.13B
$13M 0.47%
55,000
+25,000
+83% +$5.7M
SHC icon
58
Sotera Health
SHC
$5.39B
$12.9M 0.47%
+471,000
New +$12.6M
FOLD
59
PUT
DELISTED
Amicus Therapeutics
FOLD
$12.8M 0.47%
555,100
+255,100
+85% +$5.22M
CNMD icon
60
CONMED
CNMD
$1.48B
$12.7M 0.46%
113,802
-85,200
-43% -$8.07M
DMTK
61
DELISTED
DermTech, Inc. Common Stock
DMTK
$12.7M 0.46%
392,078
-10,640
-3% -$151K
OPCH icon
62
Option Care Health
OPCH
$3.57B
$12.1M 0.44%
775,000
+450,000
+138% +$6.69M
GILD icon
63
CALL
Gilead Sciences
GILD
$168B
$11.7M 0.42%
+200,000
New +$12.1M
SDGR icon
64
Schrodinger
SDGR
$1.39B
$11.1M 0.4%
140,000
+32,500
+30% +$2.04M
XRAY icon
65
PUT
Dentsply Sirona
XRAY
$2.27B
$10.8M 0.39%
+206,000
New +$10.2M
ABBV icon
66
PUT
AbbVie
ABBV
$440B
$10.7M 0.39%
+100,000
New +$9.61M
TWST icon
67
PUT
Twist Bioscience
TWST
$7.85B
$9.85M 0.36%
+69,700
New +$7.73M
HAE icon
68
Haemonetics
HAE
$4.16B
$9.8M 0.36%
82,500
+27,500
+50% +$2.96M
HRC
69
CALL
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$9.8M 0.36%
+100,000
New +$9.35M
PPD
70
DELISTED
PPD, Inc. Common Stock
PPD
$9.67M 0.35%
282,500
-317,500
-53% -$11.1M
ELV icon
71
PUT
Elevance Health
ELV
$86.6B
$9.63M 0.35%
+30,000
New +$9.21M
DXCM icon
72
DexCom
DXCM
$34.3B
$9.5M 0.35%
102,732
– –
CANO
73
DELISTED
Cano Health, Inc.
CANO
$9.32M 0.34%
+6,950
New +$7.95M
TMO icon
74
PUT
Thermo Fisher Scientific
TMO
$223B
$9.32M 0.34%
20,000
+5,000
+33% +$2.34M
MDXG icon
75
MiMedx Group
MDXG
$624M
$9.28M 0.34%
+1,021,956
New +$7.36M
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2020 Portfolio in Review

As of Q4 2020, Pura Vida Investments held 241 positions worth $2.75B, up 42% from $1.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pura Vida Investments deployed $363M of net new capital in Q4 2020, opening 88 new positions and adding to 39 existing holdings. Its largest new stake was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Inspire Medical Systems, an estimated $11.3M trimmed.

  • Pura Vida Investments's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
  • Pura Vida Investments added most to Guardant Health in Q4 2020, an estimated $9.2M increase.
  • Pura Vida Investments's biggest Q4 2020 reduction was Inspire Medical Systems, cutting an estimated $11.3M.
  • Pura Vida Investments fully exited Cooper Companies in Q4 2020, selling an estimated $27M.
  • Pura Vida Investments's ten largest holdings make up 45% of its $2.75B portfolio in Q4 2020.
  • Pura Vida Investments opened 88 new positions and closed 64 in Q4 2020.
  • Pura Vida Investments's portfolio value rose 42% quarter-over-quarter to $2.75B.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.